Evidence map›Paper›PMID 40612713›Full record

ArticleNetwork neuroscience (Cambridge, Mass.)2025

Increased functional network segregation in glioma patients posttherapy: A neurological compensatory response or catastrophe for cognition?

Laurien De Roeck, Rob Colaes, Patrick Dupont, Stefan Sunaert, Steven De Vleeschouwer, Paul M Clement, Charlotte Sleurs, Maarten Lambrecht

Abstract read
In one paragraph

Article in Network neuroscience (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laurien De RoeckDepartment of Radiation-Oncology, University Hospitals Leuven, Belgium.ORCID https://orcid.org/0000-0002-2571-1816
Rob ColaesDepartment of Imaging & Pathology, Katholieke Universiteit Leuven, Belgium.ORCID https://orcid.org/0009-0009-2553-415X
Patrick DupontLeuven Brain Institute, Katholieke Universiteit Leuven, Belgium.ORCID https://orcid.org/0000-0003-1980-2540
Stefan SunaertDepartment of Imaging & Pathology, Katholieke Universiteit Leuven, Belgium.ORCID https://orcid.org/0000-0002-1177-4680
Steven De VleeschouwerLeuven Brain Institute, Katholieke Universiteit Leuven, Belgium.ORCID https://orcid.org/0000-0002-9576-9917
Paul M ClementDepartment of Oncology, Katholieke Universiteit Leuven, Belgium.ORCID https://orcid.org/0000-0001-7600-0806
Charlotte SleursDepartment of Oncology, Katholieke Universiteit Leuven, Belgium.ORCID https://orcid.org/0000-0002-4480-8330
Maarten LambrechtDepartment of Radiation-Oncology, University Hospitals Leuven, Belgium.ORCID https://orcid.org/0000-0002-8746-2691

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The brain operates through networks of interconnected regions, which can be disrupted by glial tumors and their treatment. This study investigates associations between this altered functional network topology and cognition in gliomas. We studied 50 adult glioma survivors (>1-year posttherapy) and 50 healthy controls. Participants underwent cognitive assessments across six domains and an 8-min resting-state functional MRI. Based on the BOLD signal, partial correlations were computed among 78 brain regions. From their absolute values, whole-brain and nodal graph metrics were derived and normalized to random graphs. Group differences in whole-brain and nodal graph metrics were assessed with Mann-Whitney

Indexed as

CognitionFunctional connectivityGliomaGraph theoryHubsResting-state functional MRI

Identifiers

PMID40612713
PMCPMC12226146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.